Physician
Chen, Christopher
Chen, Christopher was paid $1.25M by Medicaid between Jan 2018 and Mar 2023, across 41 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 15% of everything it billed.
33Billing provider infoCHEN, CHRISTOPHER
PEABODY, MA 01960
PEABODY, MA 01960
33aNPI1528027125assigned 03/22/2006
33bProvider typePediatrics Physician
28Total paid$1.25M
24GClaims36,716
24DCodes billed41
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#65 of 1,273
Median peer was paid$24K
This provider vs. median52×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,926 | $304K | |
| 2019 | 10,580 | $370K | |
| 2020 | 7,187 | $249K | |
| 2021 | 5,037 | $161K | |
| 2022 | 4,024 | $129K | |
| 2023 | 962 | $34K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 2,215 | 2,157 | $191K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 14% | 5,651 | 4,367 | $178K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 3,148 | 3,056 | $173K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 10% | 1,539 | 1,537 | $129K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.1% | 1,353 | 1,351 | $113K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.8% | 1,073 | 1,067 | $85K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.5% | 889 | 889 | $81K |
| 90461 | 4.6% | 1,534 | 1,531 | $58K | |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 3.9% | 5,422 | 5,411 | $49K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.5% | 2,836 | 2,795 | $31K |
| 96127 | 2.1% | 2,604 | 2,603 | $27K | |
| 99177 | 1.4% | 775 | 775 | $18K |
29 more codes
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.4% | 628 | $18K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.4% | 243 | $17K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 2,137 | $16K |
| 99188 | 1.2% | 567 | $15K | |
| 36416 | <1% | 892 | $9K | |
| 83655 | <1% | 614 | $7K | |
| 80061 | Lipid panel | <1% | 343 | $4K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 212 | $4K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 65 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 229 | $3K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 78 | $3K |
| 99050 | <1% | 100 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 54 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 54 | $1K |
| 87081 | <1% | 177 | $1K | |
| 0071A | <1% | 30 | $1K | |
| 94760 | <1% | 508 | $1K | |
| 0001A | <1% | 27 | $1K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 12 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 38 | $897.56 |
| 92587 | <1% | 39 | $658.71 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 234 | $525.63 |
| 83718 | <1% | 61 | $515.45 | |
| 81003 | <1% | 208 | $455.26 | |
| 82465 | <1% | 61 | $273.28 | |
| 99173 | <1% | 12 | $266.64 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 15 | $228.90 |
| 99051 | <1% | 13 | $215.28 | |
| 99000 | <1% | 26 | $26.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.